Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Virology

Background:

• The COVID-19 pandemic, caused by the SARS-CoV-2 virus, remains a global health concern.
• Despite extensive research, effective therapeutics for COVID-19, especially for severe cases, are still lacking.
• The emergence of SARS-CoV-2 mutations necessitates the continuous development of anti-viral agents.

Purpose of the Study:

• To review promising repurposed drugs containing the indolyl heterocycle scaffold for anti-SARS-CoV-2 activity.
• To discuss natural and synthetic indole derivatives with potential therapeutic benefits against SARS-CoV-2.
• To explore the application of computer-aided drug design in optimizing anti-SARS-CoV-2 drug candidates.

Main Methods:

• Literature review of repurposed drugs and indole-containing compounds.
• Analysis of existing studies on anti-SARS-CoV-2 agents.
• Discussion of in silico approaches for drug optimization.

Main Results:

• Indolyl heterocycles represent a versatile scaffold found in compounds with diverse biological activities.
• Several natural and synthetic indole derivatives show promise as anti-SARS-CoV-2 agents.
• Computer-aided drug design can accelerate the identification and optimization of lead compounds.

Conclusions:

• Indole-based compounds are a promising area for the development of novel anti-SARS-CoV-2 therapeutics.
• Repurposed drugs and novel indole derivatives warrant further investigation for COVID-19 treatment.
• In silico studies are valuable tools for enhancing the efficacy of anti-viral drug discovery.